Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
128.00
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Merck & Co., Inc. Q2 Earnings Call Highlights
↗
Today 6:04 EDT
Merck & Co., Inc. (NYSE:MRK) reported second-quarter revenue of $16.6 billion, up 5% from a year earlier, driven by oncology, animal health and contributions from newer product launches. Revenue...
Via
MarketBeat
Topics
Earnings
S&P 500 Prints Fresh Record As Chips Rip And Hormuz Talks Crack The Oil Trade
↗
Today 4:01 EDT
Via
Chartmill
Topics
Stocks
MRK Q2 Deep Dive: Oncology and New Launches Drive Growth Amid Margin Compression
Today 1:40 EDT
Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.1% year on year to $16.61 billion. The c...
Via
StockStory
Which dow jones stocks are moving on Tuesday?
↗
August 04, 2026
Via
Chartmill
Merck (NYSE:MRK) Q2 Loss Narrows, Lifts Full-Year Sales Guidance
↗
August 04, 2026
Via
Chartmill
Merck (NYSE:MRK) Posts Better-Than-Expected Sales In Q2 CY2026
August 04, 2026
Global pharmaceutical company Merck (NYSE:MRK) announced better-than-expected revenue in Q2 CY2026, with sales up 5.1% year on year to $16.61 billion. The co...
Via
StockStory
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
August 04, 2026
From
Merck & Co., Inc.
Via
Business Wire
Explore the top gainers and losers within the dow jones index in today's session.
↗
August 03, 2026
Via
Chartmill
Merck Spotlights Weekly HIV Treatment, Monthly PrEP as $5B Growth Opportunity
↗
August 03, 2026
Merck & Co., Inc. (NYSE:MRK) outlined its HIV treatment and prevention strategy at an investor event following the International AIDS Conference, highlighting Phase III results for a once-weekly oral...
Via
MarketBeat
Top dow jones movers in Monday's session
↗
August 03, 2026
Via
Chartmill
What To Expect From Merck’s (MRK) Q2 Earnings
August 02, 2026
Global pharmaceutical company Merck (NYSE:MRK) will be announcing earnings results this Tuesday before market hours. Here’s what investors should know. Merck...
Via
StockStory
Top dow jones movers in Friday's session
↗
July 31, 2026
Via
Chartmill
1 Cash-Producing Stock with Promising Prospects and 2 That Underwhelm
July 31, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via
StockStory
Wednesday's session: top gainers and losers in the dow jones index
↗
July 29, 2026
Via
Chartmill
Merck Announces Fourth-Quarter 2026 Dividend
July 29, 2026
From
Merck & Co., Inc.
Via
Business Wire
Uncover the latest developments among dow jones stocks in today's session.
↗
July 28, 2026
Via
Chartmill
Exploring the top movers within the dow jones index during today's session.
↗
July 28, 2026
Via
Chartmill
Monday's session: top gainers and losers in the dow jones index
↗
July 27, 2026
Via
Chartmill
Explore the top gainers and losers within the dow jones index in today's session.
↗
July 24, 2026
Via
Chartmill
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
July 24, 2026
From
Merck & Co., Inc.
Via
Business Wire
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
↗
July 24, 2026
There are plenty of reasons to love these companies.
Via
The Motley Fool
Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer
↗
July 23, 2026
Income seekers shouldn't give up on the stock yet.
Via
The Motley Fool
These dow jones stocks are moving in today's session
↗
July 23, 2026
Via
Chartmill
What's going on in today's session: dow jones movers
↗
July 23, 2026
Via
Chartmill
1 Dow Jones Stock with Exciting Potential and 2 Facing Headwinds
July 23, 2026
While the Dow Jones (^DJI) represents industry leaders, not every stock in the index is a safe bet. Some are facing headwinds like declining demand, rising c...
Via
StockStory
Topics
Artificial Intelligence
Stocks
These dow jones stocks are moving in today's session
↗
July 22, 2026
Via
Chartmill
Stay informed with the top movers within the dow jones index on Tuesday.
↗
July 21, 2026
Via
Chartmill
Which dow jones stocks are moving on Tuesday?
↗
July 21, 2026
Via
Chartmill
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy
July 21, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Merck (NYSE:MRK)
July 20, 2026
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today